ID
43572
Beschrijving
Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole; ODM derived from: https://clinicaltrials.gov/show/NCT00316836
Link
https://clinicaltrials.gov/show/NCT00316836
Trefwoorden
Versies (2)
- 11-01-17 11-01-17 -
- 20-09-21 20-09-21 -
Geüploaded op
20 september 2021
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Cancer NCT00316836
Eligibility Breast Cancer NCT00316836
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00316836
- StudyEvent: Eligibility
C0015250 (UMLS CUI [1,2])
C0205447 (UMLS CUI [1,2])
C0205266 (UMLS CUI [1,3])
C3714726 (UMLS CUI [2])
C0405352 (UMLS CUI [3])
C0470187 (UMLS CUI [1,2])
C0006141 (UMLS CUI [1,3])
C0205266 (UMLS CUI [1,4])
C1562928 (UMLS CUI [2])
C0205341 (UMLS CUI [1,2])
C0680240 (UMLS CUI [1,3])
C0370003 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,3])
C0680240 (UMLS CUI [1,4])
C0680240 (UMLS CUI [1,2])
C0009905 (UMLS CUI [2])
C0039286 (UMLS CUI [3])
C0244404 (UMLS CUI [4])
C0732611 (UMLS CUI [5])
C1518041 (UMLS CUI [6])